Mogamulizumab-associated rash (MAR) mars its efficacy in the treatment of cutaneous lymphoma. Blanchard G, Guenova E. Br J Dermatol 2022;186:15-16.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Blanchard G, Guenova E. Mogamulizumab-associated rash (MAR) mars its efficacy in the treatment of cutaneous lymphoma. Br J Dermatol 2022;186:15-16.
PMID: 34988981